Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | AGTR1 | P30556 | 7/20 | 0.48 |
| ▸ | AGTR2 | P50052 | 7/20 | 0.48 |
| ▸ | TPH1 | P17752 | 7/20 | 0.47 |
| ▸ | TPH2 | Q8IWU9 | 7/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708426 | 0.97 | MEN1 (0.53) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9708233 | 0.94 | TPH1 (0.49) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9708124 | 0.94 | MEN1 (0.55) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9708208 | 0.93 | ALDH1A1 (0.49) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9707363 | 0.92 | AGTR1 (0.46) | MEN1KMT2AAGTR1AGTR2 | |
| SCHEMBL9707286 | 0.92 | AGTR1 (0.50) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9707996 | 0.92 | USP2 (0.52) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9708458 | 0.91 | KDM4E (0.46) | MEN1KMT2AAGTR1AGTR2 | |
| SCHEMBL9707461 | 0.91 | AGTR1 (0.48) | MEN1KMT2AAGTR1AGTR2 | |
| SCHEMBL9708297 | 0.91 | MEN1 (0.54) | MEN1KMT2AAGTR1AGTR2TPH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |